1Diekema D J, Pfaller MA, Jones RN, et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infection in the USA, Canada and Latin American[ J]. J Antimicrob Agents, 2000;13(4) :257-71. 被引量：1
3Reacher MH, Shah A, Livermore DM, et al. Bacteremia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998 :trend analysis[ J]. BMJ,2000;320(7229) :213-6. 被引量：1
4Zhang Y, Chen H, Li YM, et al. Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria [ J]. J Infect Dis, 2008 ; 198 (5) :723-30. 被引量：1
5Romani L, Bistoni F, Montagnoli C, et al. Thymosin alphal : an endogenous regulator of inflammation, immunity, and tolerance [ J]. Ann N Y Acad Sci ,2007 ; 1112 (10) :326-38. 被引量：1
6Yao W, Zhu Q, Yuan Y, et al. Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level [ J ]. J Gastroenterol Hepatol, 2007 ;22 ( 11 ) : 1866 -71. 被引量：1
2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
